Abstract:Medicinal chemistry patents contain rich information about chemical compounds. Although much effort has been devoted to extracting chemical entities from scientific literature, limited numbers of patent mining systems are publically available, probably due to the lack of large manually annotated corpora. To accelerate the development of information extraction systems for medicinal chemistry patents, the 2015 BioCreative V challenge organized a track on Chemical and Drug Named Entity Recognition from patent text (CHEMDNER patents). This track included three individual subtasks: (i) Chemical Entity Mention Recognition in Patents (CEMP), (ii) Chemical Passage Detection (CPD) and (iii) Gene and Protein Related Object task (GPRO). We participated in the two subtasks of CEMP and CPD using machine learning-based systems. Our machine learning-based systems employed the algorithms of conditional random fields (CRF) and structured support vector machines (SSVMs), respectively. To improve the performance of the NER systems, two strategies were proposed for feature engineering: (i) domain knowledge features of dictionaries, chemical structural patterns and semantic type information present in the context of the candidate chemical and (ii) unsupervised feature learning algorithms to generate word representation features by Brown clustering and a novel binarized Word embedding to enhance the generalizability of the system. Further, the system output for the CPD task was yielded based on the patent titles and abstracts with chemicals recognized in the CEMP task.The effects of the proposed feature strategies on both the machine learning-based systems were investigated. Our best system achieved the second best performance among 21 participating teams in CEMP with a precision of 87.18%, a recall of 90.78% and aF-measure of 88.94% and was the top performing system among nine participating teams in CPD with a sensitivity of 98.60%, a specificity of 87.21%, an accuracy of 94.75%, a Matthew's correlation coefficient (MCC) of 88.24%, a precision at full recall (P_full_R) of 66.57% and an area under the precision-recall curve (AUC_PR) of 0.9347. The SSVM-based CEMP systems outperformed the CRF-based CEMP systems when using the same features. Features generated from both the domain knowledge and unsupervised learning algorithms significantly improved the chemical NER task on patents.Database URL:http:// database. oxfordjournals. org/ content/ 2016/ baw049.

PatentNetML: A Novel Framework for Predicting Key Compounds in Patents Using Network Science and Machine Learning

Exploring sets of molecules from patents and relationships to other active compounds in chemical space networks

Exploiting Structural Information in Patent Specifications for Key Compound Prediction

Intelligent System for Automated Molecular Patent Infringement Assessment

$\texttt{PatentAgent}$: Intelligent Agent for Automated Pharmaceutical Patent Analysis

Machine Learning Small Molecule Properties in Drug Discovery

Drug discovery using very large numbers of patents: general strategy with extensive use of match and edit operations

Automated patent extraction powers generative modeling in focused chemical spaces

Chemi-net: a graph convolutional network for accurate drug property prediction

Mining Patents with Large Language Models Elucidates the Chemical Function Landscape

PatentMiner: topic-driven patent analysis and mining.

Predicting drug target interactions using meta-path-based semantic network analysis

Machine learning for synergistic network pharmacology: a comprehensive overview

PharmaNet: Pharmaceutical discovery with deep recurrent neural networks

A Neural Network Approach to Chemical and Gene/protein Entity Recognition in Patents

Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure

QPowered Compound2DeNovoDrugPropMax –A Novel Programmatic Tool Incorporating Deep Learning and In Silico Methods for Automated In Silico Bio- Activity Discovery for any Compound of Interest

Advanced graph and sequence neural networks for molecular property prediction and drug discovery

Finding Nuggets in Patent Portfolios: Core Patent Mining and Its Applications

Chemical named entity recognition in patents by domain knowledge and unsupervised feature learning

Meta-MolNet: A Cross-Domain Benchmark for Few Examples Drug Discovery